Agency Forms Undergoing Paperwork Reduction Act Review, 36212-36214 [2020-12807]
Download as PDF
<![CDATA[
36212
Federal Register / Vol. 85, No. 115 / Monday, June 15, 2020 / Notices
Individual TB patients may also be
respondents if critical clinical or contact
information is missing from their
referral and CureTB follows-up with
them to fill-in gaps to complete the
referral service. All 50 US states and
territories may refer TB patients to the
CureTB program. To date, CureTB has
also received referrals from Mexico and
Guatemala. Local health departments or
ICE detention facilities will submit
CureTB referral forms as they request
referral services. The number of referrals
varies widely between respondents.
To ensure adequate referral to
treatment occurs, CDC CureTB may
need to follow-up with an individual to
complete missing data fields concerning
clinical or contact information. This is
done to ensure continuity of care.
Therefore, individuals with TB are also
respondents in this information
collection. CDC’s CureTB program will
also continue working with our public
health partners in notifications and
referrals for contacts of TB cases. This
is a lesser used function of CureTB, but
burden is included below. These
respondents are health departments.
Finally, CDC staff in the CureTB
program also contact the new treating
physicians to determine patient
outcomes using CureTB Clinician Public
Health Department Follow-up Script.
The physicians are generally contacted
every two months over the course of
standard six month TB treatment, for a
total of three follow-up contacts per
patient.
The revision for this information
collection includes a small number of
changes to the CureTB Transnational
Notification information collection tool
for ease of use by the respondents, and
adding two pieces of additional data
important for clinical decision making
and patient contact. Additionally, CDC
is clarifying the specific burden
attributable to individuals within ICE
detention centers by noting this in the
Estimated Annualized Burden Hours
table. Finally, CDC is updating the
number of respondents and associated
burden based on program operations
over the last 12 months. No other
changes are proposed.
OMB approval is requested for three
years. Participation in this data
collection is voluntary. There are no
costs to respondents other than the time
required to complete the referral
documents and respond to CDC requests
for TB patient outcomes. The total
estimated annualized burden is 1,081
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Form name
Local Health Departments (LHD) in the
United States.
TB patients referred by LHD ...........................
TB patients referred by ICE ............................
TB treating physicians in new country ............
CureTB Transnational Notification .................
70
4
30/60
CureTB Transnational Notification .................
CureTB Transnational Notification .................
Clinician Public Health Department Follow-up
Script.
CureTB Contact/Source Investigation (CI/SI)
Notification.
187
587
870
1
1
3
5/60
45/60
10/60
20
5
30/60
LHD in the United States ................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–12806 Filed 6–12–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–1193]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Assessment of
Technical Assistance and Training
Approaches to Accelerate
Comprehensive Cancer Control
Outcomes to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
VerDate Sep<11>2014
17:04 Jun 12, 2020
Jkt 250001
for Public Comment and
Recommendations’’ notice on December
6, 2019 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies’ estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
E:\FR\FM\15JNN1.SGM
15JNN1
36213
Federal Register / Vol. 85, No. 115 / Monday, June 15, 2020 / Notices
Proposed Project
Assessment of Technical Assistance
and Training Approaches to Accelerate
Comprehensive Cancer Control
Outcomes (OMB Control No. 0920–
1193, Exp. 7/31/2019)—Reinstatement
with Change—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Cancer is the second leading cause of
death in the United States, and health
care costs for cancer care are expected
to rise to $158 billion by 2020.
Addressing this public health problem
requires primary prevention, early
detection and treatment, support for
cancer survivors, and a reduction in
health disparities. Providing support to
state, tribal, territorial and local
organizations to implement evidencebased strategies has the potential to
impact population-level cancer
outcomes and reduce the burden of
cancer.
The Centers for Disease Control and
Prevention’s (CDC) National
Comprehensive Cancer Control Program
(NCCCP) has been a primary funder for
state and community-based cancer
control interventions since its inception
in the late 1990s. The program supports
states and communities in developing a
comprehensive approach to cancer
prevention and control that includes
supporting an infrastructure for state,
local, and population-based
interventions and multi-sectoral
partnerships and coalitions. Currently,
NCCCP supports 66 cancer control
program grantees including programs in
all 50 states, the District of Columbia,
and in a number of tribes, tribal
organizations, and U.S. Associated
Pacific Islands/territories.
In striving to build capacity and
maximize the impact of CDC’s funded
programs, CDC has focused on
developing and implementing
innovative programs to enhance training
and technical assistance (TTA)
delivered to NCCCP awardees. CDC
funds two awardees under a cooperative
agreement—Provision of Technical
Assistance and Training to Assure
Comprehensive Cancer Control
Outcomes (DP18–1805). DP18–1805
awardees are charged with developing
and delivering high-quality TTA for
NCCCP funded programs, coalition
members, and partners focused on
improving implementation of evidencebased strategies for cancer prevention
and control. The TTA activities DP18–
1805 awardees implement include (1)
conduct of needs assessment, (2)
develop framework for building CCC
capacity, (3) coordinate and collaborate
with existing partners, (4) develop a
TTA plan, (5) implement a TTA plan
and conduct performance monitoring
and continuous quality improvement;
and (6) conduct a comprehensive
evaluation of TTA.
CDC proposes to conduct an
assessment of DP18–1805 awardees to:
(1) Document the nature of the TTA
provided by DP18–1805 awardees and
the extent to which the cooperative
agreement was able to achieve planned
short-term outcomes; and (2) identify
the extent to which DP18–1805 TTA
efforts contributed to NCCCP funded
programs’ achievement in program
outcomes. There are no other data
collection efforts currently underway to
assess implementation or perceived
effectiveness of TTA under DP18–1805.
This information collection request
will involve two complementary data
collection efforts: (1) Case studies of
DP18–1805 awardees (consisting of
interviews with DP18–1805 TTA
provider program managers/directors,
DP18–1805 TTA provider evaluators,
and DP18–1805 TTA provider partners)
and (2) a cross-sectional web-based
survey administered to NCCCP program
directors and staff, NCCCP coalition
members, and NCCCP partners. The
case studies will be used to explore how
DP18–1805 awardees are implementing
their respective cooperative agreements
and administering TTA to NCCCP
awardees; the factors that affect the
implementation of specific TTA
components; and the extent to which
they were able to achieve planned shortterm outcomes. The web-based survey
will inform CDC’s understanding of the
reach of DP18–1805 TTA efforts; elicit
information from NCCCP programs and
coalitions about the TTA received,
including type, dosage, frequency and
format; and assess the perceptions of the
effectiveness of the TTA.
CDC will use findings from the
assessment to inform development of
future TTA efforts to more effectively
and efficiently support NCCCP’s partner
organizations. OMB approval is
requested for three years. Participation
is voluntary and respondents will not
receive incentives for participation.
There are no costs to respondents other
than their time. The total estimated
annualized burden is 51 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Form name
NCCCP Awardee Program Directors and
Staff.
NCCCP Coalition Members, and NCCCP
Partners.
TTA Provider Organizations ...........................
Web-based survey .........................................
88
1
15/60
Web-based survey .........................................
88
1
15/60
Worksheet for Identifying Case Study
Interviewees.
Case Study Interview Guide for TTA Provider Program Directors or Managers.
Case Study Interview Guide for TTA Provider Evaluators.
Case Study Interview Guide for TTA Provider Partners.
1
1
1
1
1
90/60
1
1
1
3
1
1
TTA Provider Directors or Managers ..............
TTA Provider Evaluators .................................
TTA Provider Partners ....................................
jbell on DSKJLSW7X2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Type of respondents
VerDate Sep<11>2014
17:04 Jun 12, 2020
Jkt 250001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
E:\FR\FM\15JNN1.SGM
15JNN1
36214
Federal Register / Vol. 85, No. 115 / Monday, June 15, 2020 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–12807 Filed 6–12–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–0909; Docket No. CDC–2020–
0070]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on CDC Diabetes Prevention
Recognition Program (DPRP). This
collection allows CDC to administer the
Diabetes Prevention Recognition
Program (DPRP) and collects
information needed by the Centers for
Medicare & Medicaid Services (CMS) to
support the Medicare Expanded Model
(Medicare Diabetes Prevention Program
[MDPP]).
DATES: CDC must receive written
comments on or before August 14, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0070 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:04 Jun 12, 2020
Jkt 250001
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
CDC Diabetes Prevention Recognition
Program (DPRP)—Revision—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC’s Division of Diabetes
Translation (DDT) established and
administers the National DPP’s Diabetes
Prevention Recognition Program
(DPRP), which recognizes organizations
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
that deliver diabetes prevention
programs according to evidence-based
requirements set forth in the ‘‘Centers
for Disease Control and Prevention
Diabetes Prevention Recognition
Program Standards and Operating
Procedures’’ (DPRP Standards).
Additionally, the Centers for Medicare
and Medicaid Services (CMS) Medicare
Diabetes Prevention Program (MDPP)
expansion of CDC’s National DPP was
announced in early 2016, when the
Secretary of Health and Human Services
determined that the Diabetes Prevention
Program met the statutory criteria for
inclusion in Medicare’s expanded list of
healthcare services for beneficiaries
(https://innovation.cms.gov/initiatives/
medicare-diabetes-prevention-program/
). This is the first time a preventive
service model from the CMS Innovation
(CMMI) Center has been expanded.
After extensive testing of the DPP model
in 17 sites across the U.S. in 2014–2016,
CMS proposed the MDPP in Sections
1102 and 1871 of the Social Security
Act (42 U.S.C. 1302 and 1395hh
§ 424.59), authorizing CDC-recognized
organizations to prepare for enrollment
as MDPP suppliers beginning in January
2018 in order to bill CMS for these
services. Only organizations in good
standing with the CDC DPRP are eligible
as MDPP suppliers. CDC continues to
work with CMS to support the MDPP.
CDC requests an additional three
years of OMB approval to continue
collecting the information needed to
administer the DPRP and information
needed by CMS to support the MDPP
benefit. Based on experience with the
DPRP from 2011–2020, including data
analysis, and feedback from applicant
organizations and internal and external
partners, CDC plans to revise the DPRP
Standards and the associated
information collection.
Key changes are a direct result of
DPRP data analyses and discussion with
National DPP stakeholders, including
those serving vulnerable populations.
Key changes allow for the optional
collection of Hemoglobin A1C levels,
and for weight/physical activity minutes
to be combined (a new method), to
determine Full recognition; the required
collection of Application Delivery Mode
questions; revised organizational type
information; program enrollment
motivation/enrollment source
information; adding Gender; and the
removal of Session ID.
Three data elements have been
minimally revised and no other data
elements have been added to the onetime application form; and, three
elements have been revised, one has
been deleted, and four have been added
E:\FR\FM\15JNN1.SGM
15JNN1
]]>Agencies
[Federal Register Volume 85, Number 115 (Monday, June 15, 2020)]
[Notices]
[Pages 36212-36214]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12807]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-1193]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Assessment of Technical Assistance and
Training Approaches to Accelerate Comprehensive Cancer Control Outcomes
to the Office of Management and Budget (OMB) for review and approval.
CDC previously published a ``Proposed Data Collection Submitted for
Public Comment and Recommendations'' notice on December 6, 2019 to
obtain comments from the public and affected agencies. CDC received one
comment related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies' estimate of the burden
of the proposed collection of information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
[[Page 36213]]
Proposed Project
Assessment of Technical Assistance and Training Approaches to
Accelerate Comprehensive Cancer Control Outcomes (OMB Control No. 0920-
1193, Exp. 7/31/2019)--Reinstatement with Change--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Cancer is the second leading cause of death in the United States,
and health care costs for cancer care are expected to rise to $158
billion by 2020. Addressing this public health problem requires primary
prevention, early detection and treatment, support for cancer
survivors, and a reduction in health disparities. Providing support to
state, tribal, territorial and local organizations to implement
evidence-based strategies has the potential to impact population-level
cancer outcomes and reduce the burden of cancer.
The Centers for Disease Control and Prevention's (CDC) National
Comprehensive Cancer Control Program (NCCCP) has been a primary funder
for state and community-based cancer control interventions since its
inception in the late 1990s. The program supports states and
communities in developing a comprehensive approach to cancer prevention
and control that includes supporting an infrastructure for state,
local, and population-based interventions and multi-sectoral
partnerships and coalitions. Currently, NCCCP supports 66 cancer
control program grantees including programs in all 50 states, the
District of Columbia, and in a number of tribes, tribal organizations,
and U.S. Associated Pacific Islands/territories.
In striving to build capacity and maximize the impact of CDC's
funded programs, CDC has focused on developing and implementing
innovative programs to enhance training and technical assistance (TTA)
delivered to NCCCP awardees. CDC funds two awardees under a cooperative
agreement--Provision of Technical Assistance and Training to Assure
Comprehensive Cancer Control Outcomes (DP18-1805). DP18-1805 awardees
are charged with developing and delivering high-quality TTA for NCCCP
funded programs, coalition members, and partners focused on improving
implementation of evidence-based strategies for cancer prevention and
control. The TTA activities DP18-1805 awardees implement include (1)
conduct of needs assessment, (2) develop framework for building CCC
capacity, (3) coordinate and collaborate with existing partners, (4)
develop a TTA plan, (5) implement a TTA plan and conduct performance
monitoring and continuous quality improvement; and (6) conduct a
comprehensive evaluation of TTA.
CDC proposes to conduct an assessment of DP18-1805 awardees to: (1)
Document the nature of the TTA provided by DP18-1805 awardees and the
extent to which the cooperative agreement was able to achieve planned
short-term outcomes; and (2) identify the extent to which DP18-1805 TTA
efforts contributed to NCCCP funded programs' achievement in program
outcomes. There are no other data collection efforts currently underway
to assess implementation or perceived effectiveness of TTA under DP18-
1805.
This information collection request will involve two complementary
data collection efforts: (1) Case studies of DP18-1805 awardees
(consisting of interviews with DP18-1805 TTA provider program managers/
directors, DP18-1805 TTA provider evaluators, and DP18-1805 TTA
provider partners) and (2) a cross-sectional web-based survey
administered to NCCCP program directors and staff, NCCCP coalition
members, and NCCCP partners. The case studies will be used to explore
how DP18-1805 awardees are implementing their respective cooperative
agreements and administering TTA to NCCCP awardees; the factors that
affect the implementation of specific TTA components; and the extent to
which they were able to achieve planned short-term outcomes. The web-
based survey will inform CDC's understanding of the reach of DP18-1805
TTA efforts; elicit information from NCCCP programs and coalitions
about the TTA received, including type, dosage, frequency and format;
and assess the perceptions of the effectiveness of the TTA.
CDC will use findings from the assessment to inform development of
future TTA efforts to more effectively and efficiently support NCCCP's
partner organizations. OMB approval is requested for three years.
Participation is voluntary and respondents will not receive incentives
for participation. There are no costs to respondents other than their
time. The total estimated annualized burden is 51 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
NCCCP Awardee Program Directors and Web-based survey........ 88 1 15/60
Staff.
NCCCP Coalition Members, and NCCCP Web-based survey........ 88 1 15/60
Partners.
TTA Provider Organizations............ Worksheet for 1 1 1
Identifying Case Study
Interviewees.
TTA Provider Directors or Managers.... Case Study Interview 1 1 90/60
Guide for TTA Provider
Program Directors or
Managers.
TTA Provider Evaluators............... Case Study Interview 1 1 1
Guide for TTA Provider
Evaluators.
TTA Provider Partners................. Case Study Interview 3 1 1
Guide for TTA Provider
Partners.
----------------------------------------------------------------------------------------------------------------
[[Page 36214]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-12807 Filed 6-12-20; 8:45 am]
BILLING CODE 4163-18-P
